New imaging technology to understand tumors and other diseases
Preclinical Electron Paramagnetic Resonance Tumor Imager
This study is testing a new, portable imaging system that can help doctors see important details about tumors and other health issues by measuring things like oxygen levels and free radicals, which could lead to better treatment options for patients with cancer and other conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Denver (Colorado Seminary) NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project ID | NIH-10881902 on NIH RePORTER |
What this research studies
This research focuses on developing a novel electron paramagnetic resonance (EPR) imaging system that can measure important physiological parameters like oxygen levels and redox status in tumors and other conditions. By utilizing advanced techniques, the study aims to provide insights into how free radicals affect cancer and other diseases, potentially guiding treatment decisions. The system will be compact and transportable, making it suitable for both clinical and pharmaceutical applications. The research will involve testing this technology in mouse models to assess its effectiveness in various medical scenarios, including cancer treatment and acute lung injury.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer, acute lung injury, or other conditions related to oxidative stress and free radical activity.
Not a fit: Patients with conditions unrelated to oxidative stress or those who do not have access to the imaging technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for cancer and other serious conditions by providing real-time insights into tumor biology.
How similar studies have performed: Other research has shown promise in using EPR imaging techniques, suggesting that this approach could be a significant advancement in understanding and treating various diseases.
Where this research is happening
Denver, United States
- University of Denver (Colorado Seminary) — Denver, United States (Active)
Researchers
- Principal investigator: Eaton, Gareth R — University of Denver (Colorado Seminary)
- Study coordinator: Eaton, Gareth R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.